 Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen ScreeningMain Category: Prostate / Prostate CancerArticle Date: 11 Feb 2013 Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening. Men must consider how they value different potential outcomes to make good decisions about PSA screening, according to the study. The trial included 911 men (ages 50 to 70 years) from the United States and Australia who had average risk for prostate cancer. "The participants who received the rating and ranking task were more likely to report reducing the chance of death from prostate cancer as being most important (54.4 percent) ... Further studies with more distal outcome measures are needed to determine the best method of values clarification, if any, for decisions such as whether to undergo screening with PSA." Original article posted on Medical News Today. Articles not to be reproduced without permission of Medical News Today Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles. < back to medical news
|
||||
|
news headlines 
email to a friend 
printer friendly 
sign up to newsletter 
Privacy Policy | Disclaimer | Contact / Feedback
MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2013 All rights reserved.
